Rising High: Clearmind granted patent approval for binge behavior treatment
PremiumThe FlyRising High: Clearmind granted patent approval for binge behavior treatment
28d ago
Rising High: Exclusive talk with psilocybin CPG brand PATOO
Premium
The Fly
Rising High: Exclusive talk with psilocybin CPG brand PATOO
1M ago
Scientific journal retracts three papers on MDMA-assisted therapy, NYT reports
Premium
The Fly
Scientific journal retracts three papers on MDMA-assisted therapy, NYT reports
1M ago
Compass Pathways reports Q2 EPS (56c), consensus (53c)
PremiumThe FlyCompass Pathways reports Q2 EPS (56c), consensus (53c)
2M ago
Compass Pathways announces second quarter 2024 financial results and business highlights
Premium
Press Releases
Compass Pathways announces second quarter 2024 financial results and business highlights
2M ago
Compass Pathways to announce second quarter financial results on August 1, 2024
Premium
Press Releases
Compass Pathways to announce second quarter financial results on August 1, 2024
2M ago
Compass Pathways appoints Lori Englebert as Chief Commercial Officer
PremiumThe FlyCompass Pathways appoints Lori Englebert as Chief Commercial Officer
3M ago
Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Premium
Press Releases
Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
3M ago
Here’s What You Missed in Cannabis, Psychedelics This Week
Premium
The Fly
Here’s What You Missed in Cannabis, Psychedelics This Week
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100